The patient presented with a metastatic recurrence of prostate adenocarcinoma, showing a significant PSMA uptake (Standardized Uptake Value Maximum, SUVmax: 17.1) in an atypical location, the pituitary gland. This evidence concerns the gene FOLH1 and prostate adenocarcinoma.